None listed
Conditions
Interventions
Intervention1: HTSS-052203: 3 to 5 drops of test product to be applied on face and massage gently until it gets absorbed. To be used once a day.
Control Intervention1: None: None
Sponsors
Himalaya Wellness Company
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subject has at least 2 dark spots on the face (suntan, blemishes, sunspots and age-spots). Preferably equal number of subjects will be recruited in all indications. 2) Subjects with mild to moderate dark spots as per Investigator global assessment (IGA). 3) Subjects with oily skin having Sebumeter measurement > 180 (μg/cm2).
Exclusion criteria
Exclusion criteria: 1) Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments. 2) Subjects who are receiving topical or systemic treatments / undergoing skin lightening treatment. 3) Subjects receiving medications (e.g., steroids or antihistamines) which would compromise the study. 4) Subjects with chronic illness which may influence the cutaneous state. 5) Subjects having history of diabetes, acute cardiac and circulatory diseases, HIV, hepatitis. 6) Subjects using other marketed anti-acne/anti-aging/skin lightening products during the study period or in the past 6 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Assessment of dark spots using Investigator global assessment (IGA). 2) Assessment of skin pigment using 9-point scale. 3) Assessment of dark spots using Mexameter. 4) Assessment of skin sebum level using SebumeterTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 282) Assessment of skin pigment using 9-point scale. 3) Assessment of dark spots using Mexameter. 4) Assessment of skin sebum level using Sebumeter | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of Skin gloss using Skin-GlossymeterTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of Skin Moisturization using Corneometer / MoistureMeterSCTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of Skin radiance using Modified Griffiths ScaleTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of Subject Satisfaction Questionnaire after product usageTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of the colour of dark spot using ChromameterTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of uneven skin tone using Felix Von Luschan Skin colour chartTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of skin elasticity using CutometerTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of dark spots and skin texture (roughness) using 3D analysis systemTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28;Assessment of Product Response Index (Perception about Product) after product usageTimepoint: Day 28;Assessment of skin barrier function by measuring Transepidermal Water Loss (TEWL) using TEWAmeter / VapometerTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 28 | — |
Countries
India
Contacts
Public ContactDr Simran Sethi
Cliantha Research
Outcome results
None listed